Okay, let's tackle this question. The user provided a question about the most common familial hyperlipidaemia in children. The correct answer is missing, but the options are labeled A to D. First, I need to recall the different types of familial hyperlipidaemias and their prevalence in pediatric populations.

Familial hyperlipidaemias are inherited disorders that lead to elevated lipid levels. The main types are Familial Hypercholesterolemia (FH), Familial Combined Hyperlipidemia (FCH), and others like Familial Hypertriglyceridemia. FH is caused by mutations in the LDL receptor gene, leading to high LDL cholesterol. It's known to present early in life, even in children, because of the autosomal dominant inheritance.

Looking at the options, even though the letters aren't filled in, the correct answer is likely FH. The other options would be less common in children. For example, FCH is more common in adults and presents with variable lipid abnormalities. Familial Hypertriglyceridemia is more about high triglycerides, which might not be the most common in children.

I need to structure the explanation with the required sections. Start with the core concept: FH is the most common inherited lipid disorder in children due to LDL receptor defects. Then explain why FH is correct, mentioning the pathophysiology. Then address the other options as incorrect, explaining their differences. Add a clinical pearl about early screening in FH. Finally, confirm the correct answer as FH.

**Core Concept**
Familial hyperlipidaemias are inherited lipid disorders with distinct clinical presentations. **Familial Hypercholesterolemia (FH)** is the most common form in children, characterized by autosomal dominant inheritance and defective **LDL receptor function**, leading to severe hypercholesterolemia and premature atherosclerosis.

**Why the Correct Answer is Right**
**Familial Hypercholesterolemia (FH)** arises from mutations in the *LDLR*, *APOB*, or *PCSK9* genes, impairing LDL clearance. Children with FH exhibit elevated LDL cholesterol (>190 mg/dL in heterozygous cases), xanthomas, and corneal arcus. Early diagnosis is critical to prevent cardiovascular complications. FH accounts for 1 in 250–300 live births, making it the most prevalent monogenic lipid disorder in pediatric populations.

**Why Each Wrong Option is Incorrect**
**Option A:** *Familial Combined Hyperlipidemia* presents with variable lipid profiles (elevated LDL, VLDL, or both) but is less common in children and peaks in adulthood.
**Option B:** *Familial Hypertriglyceridemia* involves elevated triglycerides, not LDL cholesterol, and is typically diagnosed in adolescence or adulthood.
**Option C:** *Familial Lipo-protein Lipase Deficiency* causes chylomicronemia and eruptive xanthomas but is rare and presents with acute pancreatitis risk.

**Clinical Pearl / High-Yield Fact**
Never overlook **FH in pediatric patients with family history of premature CAD**. Early lipid screening (age 1–2 years) and cascade testing are vital. Remember the **"FH phenotype": xanthomas, corneal arcus, and family history of young MI**

✓ Correct Answer: D. Combined hyperlipidaemia